Cargando…

Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes

Objective: To investigate the correlation between the structure and function alterations of gut microbiota and biochemical indicators in males with hyperuricemia (HUA) and high levels of liver enzymes, in order to provide new evidences and therapeutic targets for the clinical diagnosis and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Shifeng, Chen, Jingfeng, Zhang, Yuheng, Qin, Qian, Li, Weikang, Yan, Su, Wang, Youxiang, Li, Tiantian, Gao, Xinxin, Tang, Lin, Li, Ang, Ding, Suying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640097/
https://www.ncbi.nlm.nih.gov/pubmed/34869502
http://dx.doi.org/10.3389/fmed.2021.779994
_version_ 1784609266476253184
author Sheng, Shifeng
Chen, Jingfeng
Zhang, Yuheng
Qin, Qian
Li, Weikang
Yan, Su
Wang, Youxiang
Li, Tiantian
Gao, Xinxin
Tang, Lin
Li, Ang
Ding, Suying
author_facet Sheng, Shifeng
Chen, Jingfeng
Zhang, Yuheng
Qin, Qian
Li, Weikang
Yan, Su
Wang, Youxiang
Li, Tiantian
Gao, Xinxin
Tang, Lin
Li, Ang
Ding, Suying
author_sort Sheng, Shifeng
collection PubMed
description Objective: To investigate the correlation between the structure and function alterations of gut microbiota and biochemical indicators in males with hyperuricemia (HUA) and high levels of liver enzymes, in order to provide new evidences and therapeutic targets for the clinical diagnosis and treatment of HUA. Methods: A total of 69 patients with HUA (HUA group) and 118 healthy controls were enrolled in this study. Their age, height, waist circumference, weight, and pressure were measured. The clinical parameters such as fasting plasma glucose (FBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum uric acid (SUA), serum creatinine (Scr), total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), white blood cell (WBC), platelet (PLT), and absolute value of neutrophils (NEUT) were examined. We used whole-genome shotgun sequencing technology and HUMAnN2 MetaCyc pathway database to detect the composition and pathways of the gut microbiota. The main statistical methods were student's t test, chi-square tests, and Wilcoxon rank sum test. The correlations among bacterial diversity, microbial pathways, and biochemical indicators were evaluated by the R function “cor.test” with spearman method. Results: The gut bacterial diversity in HUA group reduced significantly and the community of the microbiota was of significant difference between the two groups. The pathways that can produce 5-aminoimidazole ribonucleotide (PWY-6122, PWY-6277, and PWY-6121), aromatic amino acids, and chorismate (COMPLETE-ARO-PWY, ARO-PWY, and PWY-6163) were enriched in the HUA group; while the pathways that can produce short-chain fatty acids (SCFAs, such as CENTFERM-PWY and PWY-6590) and the gut microbiotas that can produce SCFAs (Roseburia hominis, Odoribacter splanchnicus, Ruminococcus callidus, Lachnospiraceae bacterium 3_1_46FAA, Bacteroides uniformis, Butyricimonas synergistica) and equol (Adlercreutzia equolifaciens) were enriched in healthy controls. Conclusion: The structure and function of the gut microbiota in males with HUA and high levels of liver enzymes have altered apparently. In-depth study of related mechanisms may provide new ideas for the treatment of HUA.
format Online
Article
Text
id pubmed-8640097
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86400972021-12-04 Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes Sheng, Shifeng Chen, Jingfeng Zhang, Yuheng Qin, Qian Li, Weikang Yan, Su Wang, Youxiang Li, Tiantian Gao, Xinxin Tang, Lin Li, Ang Ding, Suying Front Med (Lausanne) Medicine Objective: To investigate the correlation between the structure and function alterations of gut microbiota and biochemical indicators in males with hyperuricemia (HUA) and high levels of liver enzymes, in order to provide new evidences and therapeutic targets for the clinical diagnosis and treatment of HUA. Methods: A total of 69 patients with HUA (HUA group) and 118 healthy controls were enrolled in this study. Their age, height, waist circumference, weight, and pressure were measured. The clinical parameters such as fasting plasma glucose (FBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum uric acid (SUA), serum creatinine (Scr), total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), white blood cell (WBC), platelet (PLT), and absolute value of neutrophils (NEUT) were examined. We used whole-genome shotgun sequencing technology and HUMAnN2 MetaCyc pathway database to detect the composition and pathways of the gut microbiota. The main statistical methods were student's t test, chi-square tests, and Wilcoxon rank sum test. The correlations among bacterial diversity, microbial pathways, and biochemical indicators were evaluated by the R function “cor.test” with spearman method. Results: The gut bacterial diversity in HUA group reduced significantly and the community of the microbiota was of significant difference between the two groups. The pathways that can produce 5-aminoimidazole ribonucleotide (PWY-6122, PWY-6277, and PWY-6121), aromatic amino acids, and chorismate (COMPLETE-ARO-PWY, ARO-PWY, and PWY-6163) were enriched in the HUA group; while the pathways that can produce short-chain fatty acids (SCFAs, such as CENTFERM-PWY and PWY-6590) and the gut microbiotas that can produce SCFAs (Roseburia hominis, Odoribacter splanchnicus, Ruminococcus callidus, Lachnospiraceae bacterium 3_1_46FAA, Bacteroides uniformis, Butyricimonas synergistica) and equol (Adlercreutzia equolifaciens) were enriched in healthy controls. Conclusion: The structure and function of the gut microbiota in males with HUA and high levels of liver enzymes have altered apparently. In-depth study of related mechanisms may provide new ideas for the treatment of HUA. Frontiers Media S.A. 2021-11-19 /pmc/articles/PMC8640097/ /pubmed/34869502 http://dx.doi.org/10.3389/fmed.2021.779994 Text en Copyright © 2021 Sheng, Chen, Zhang, Qin, Li, Yan, Wang, Li, Gao, Tang, Li and Ding. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Sheng, Shifeng
Chen, Jingfeng
Zhang, Yuheng
Qin, Qian
Li, Weikang
Yan, Su
Wang, Youxiang
Li, Tiantian
Gao, Xinxin
Tang, Lin
Li, Ang
Ding, Suying
Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title_full Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title_fullStr Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title_full_unstemmed Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title_short Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes
title_sort structural and functional alterations of gut microbiota in males with hyperuricemia and high levels of liver enzymes
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640097/
https://www.ncbi.nlm.nih.gov/pubmed/34869502
http://dx.doi.org/10.3389/fmed.2021.779994
work_keys_str_mv AT shengshifeng structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT chenjingfeng structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT zhangyuheng structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT qinqian structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT liweikang structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT yansu structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT wangyouxiang structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT litiantian structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT gaoxinxin structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT tanglin structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT liang structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes
AT dingsuying structuralandfunctionalalterationsofgutmicrobiotainmaleswithhyperuricemiaandhighlevelsofliverenzymes